Limited-field radiation therapy in the management of early-stage breast cancer

Journal of the National Cancer Institute

Volumn 95, Issue 16, 2003, Pages 1205-1211

  Vicini, Frank A ^a   Kestin, Larry ^a   Chen, Peter ^a   Benitez, Pamela ^a   Goldstein, Neal S ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONFIDENCE INTERVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION FIELD; STATISTICAL SIGNIFICANCE; ADJUVANT THERAPY; BREAST TUMOR; INTRAOPERATIVE PERIOD; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SEGMENTAL MASTECTOMY; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; BRACHYTHERAPY; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE PERIOD; MASTECTOMY, SEGMENTAL; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SINGLE-BLIND METHOD; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0042641528     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg023     Document Type: Article

References (32)

1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32.
2. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
3. Rosen PP, Fracchia AA, Urban JA, Schottenfeld D, Robbins GF. "Residual" mammary carcinoma following simulated partial mastectomy. Cancer 1975;35:739-47.
4. Sobin LH, Wittekind C. International Union Against Cancer. TNM classification of malignant tumours. 5th ed. New York (NY): Wiley; 1997.
5. Kestin LL, Jaffray DA, Edmundson GK, Martinez AA, Wong JW, Kini VR, et al. Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys 2000;46:35-43.
6. Vicini FA, Kestin LL, Edmundson GK, Jaffray DA, Wong JW, Kini VR, et al. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys 1999;45:803-10.
7. Recht A, Silver B, Schnitt S, Connolly J, Hellman S, Harris JR. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 1985; 11: 1271-6.
8. Harris J, Levine M, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 1979;5:257-61.
9. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;457-9.
10. Mantel L. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
11. Cox JD. Regression models and life-tables. J R Stat Soc B 1972;34: 187-220.
12. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991;19;403-10. Histopathology 2002;41(3A):151.
13. Moon WK, Noh DY, Im JG. Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients. Radiology 2002;224:569-76.
14. Orel SG, Schnall MD, Powell CM, Hochman MG, Solin LJ, Fowble BL, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995;196:115-22.
15. Schnitt SJ, Hayman J, Gelman R, Eberlein TJ, Love SM, Mayzel K, et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 1996;77:1094-100.
16. Moffat FL, Ketcham AS. Breast-conserving surgery and selective adjuvant radiation therapy for stage I and II breast cancer. Semin Surg Oncol 1992; 8:172-6.
17. Clark RM, Wilkinson RH, Miceli PN, MacDonald WD. Breast cancer. Experiences with conservation therapy. Am J Clin Oncol 1987;10:461-8.
18. Kato T, Kimura T, Ishii N, Fujii A, Yamamoto K, Kameoka S, et al. Pathologic evaluation of surgical margins and local recurrences after breast-conserving surgery without irradiation. World J Surg 2000;24: 328-33.
19. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001;12: 997-1003.
20. Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. The Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst 1990;82:1851.
21. Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992;84:683-9.
22. Gage I, Recht A, Gelman R, Nixon AJ, Silver B, Bornstein BA, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995;33:245-51.
23. Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology. Cancer 2002;95:2059-67.
24. Pierquin B, Huart J, Raynal M, Otmezguine Y, Calitchi E, Mazeron JJ, et al. Conservative treatment for breast cancer: long-term results (15 years). Radiother Oncol 1991;20:16-23.
25. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 1993;5:278-83.
26. Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002;80:121-8.
27. King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins TG, Jiang XZ. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000;180:299-304.
28. Smith TE, Lee D, Turner BC, Carter D, Haffty BG. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000;48: 1281-9.
29. Morrow M. Rational local therapy for breast cancer. N Engl J Med 2002; 347:1270-1.
30. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000;355:1757-70.
31. Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 2001;37: 2178-83.
32. Vaidya JS, Baum M, Tobias JS, D'Souza DP, Naidu SV, Morgan S, et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 2001;12:1075-80.